Head to Head Analysis: Aimei Health Technology (AFJK) & Its Rivals

Aimei Health Technology (NASDAQ:AFJK) is one of 89 public companies in the “UNCLASSIFIED” industry, but how does it compare to its peers? We will compare Aimei Health Technology to similar companies based on the strength of its profitability, analyst recommendations, valuation, risk, earnings, institutional ownership and dividends.

Institutional & Insider Ownership

45.6% of Aimei Health Technology shares are owned by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are owned by institutional investors. 2.5% of Aimei Health Technology shares are owned by insiders. Comparatively, 42.9% of shares of all “UNCLASSIFIED” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Aimei Health Technology and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Analyst Ratings

This is a breakdown of current recommendations and price targets for Aimei Health Technology and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	0	1	0	0	2.00
Aimei Health Technology Competitors	231	266	217	3	1.99

As a group, “UNCLASSIFIED” companies have a potential upside of 101.09%. Given Aimei Health Technology’s peers higher possible upside, analysts clearly believe Aimei Health Technology has less favorable growth aspects than its peers.

Risk & Volatility

Aimei Health Technology has a beta of -0.02, meaning that its share price is 102% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s peers have a beta of -0.09, meaning that their average share price is 109% less volatile than the S&P 500.

Earnings & Valuation

This table compares Aimei Health Technology and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	50.87
Aimei Health Technology Competitors	$203.60 million	-$18.54 million	94.34

Aimei Health Technology’s peers have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Aimei Health Technology peers beat Aimei Health Technology on 9 of the 13 factors compared.

About Aimei Health Technology

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.